We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Balanced Reporting. Trusted Insights.
Saturday, January 23, 2021
Patents held by the MIT-Harvard Broad Institute for the use of the gene-editing tool CRISPR-Cas9 have been upheld by a federal appeals court, potentially bringing to an end a battle between the institute and the University of California, Berkeley.
J.R. Simplot Company has executed a joint intellectual property licensing agreement with Corteva Agriscience and the Broad Institute of MIT and Harvard for foundational CRISPR-Cas9 and related gene editing tools.
Historically, farmers and ranchers have looked to USDA and their universities to develop the “next big thing” in plant and animal breeding, but exciting new players are emerging.
WASHINGTON, Oct. 25, 2017 - Two organizations that control the licensing of much of the foundational CRISPR-Cas9 genome editing intellectual property for use in agriculture decided to work together to make these tools available non-exclusively, removing roadblocks to expanded use of this technology.